Lv5
928 积分 2022-01-16 加入
Opportunities and limitations of B cell depletion approaches in SLE
4小时前
已完结
Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus
13天前
已完结
PCSK9 and Inflammation: Their Role in Autoimmune Diseases, with a Focus on Rheumatoid Arthritis and Systemic Lupus Erythematosus
13天前
已完结
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Associated with Disease Activity and Risk of Incident Cardiovascular Disease in Patients with Systemic Lupus Erythematosus
13天前
已完结
Association between genetically proxied PCSK9 inhibition and systemic lupus erythematosus risk: A mendelian randomization study
13天前
已完结
Issue Information
13天前
已完结
Kidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?
19天前
已完结
PCSK9 in diabetic kidney disease
19天前
已完结
PCSK9 causes inflammation and cGAS/STING pathway activation in diabetic nephropathy
19天前
已完结
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in patients with end‐stage renal disease
19天前
已完结
皖公网安备34019202002308
